A 15-year prospective cohort study in high-risk women.
Breast cancer risk elevated with combination HRT, but not estrogen alone.
Laparoscopy and robotic-assisted surgery showed similar patient-reported outcomes.
The initiative was launched at the ESTRO 37 conference last weekend.
Adherence to the Mediterranean diet has a reverse effect.
A previous noncomparative series involving 22 patients suggested administration of talc may achieve high rates of pleurodesis.
FDA also approved companion diagnostic test.
At the current rate, the NHS will be unable to identify the detectable pool of BRCA carriers in the general population.
Meta-analysis of 61 studies.
Addition of trastuzumab to carboplatin and paclitaxel was well tolerated.
Counterfeit oncology drugs are reaching healthcare professionals through both legal and illegal supply chains, the authors of a new report say.
New research has found that almost 40% of cancer cases in the United Kingdom are attributable to lifestyle factors.
The Northern Ireland Cancer Registry has published its latest statistics.
Results from the EMBRACE study, the largest prospective cohort study of breast and ovarian cancer risk in BRCA1/BRCA2 predictive test negatives.
Intrauterine sampling increases sensitivity and specificity.
Rubraca decreases tumour growth in cancer patients with or without deficiencies in BRCA.
One in five BRCA carriers would have been missed using previous criteria for genetic testing.
